New imagebackground photo
media

News and Publications

Read the latest news, announcements, and research from IMIDomics.
Photo
Publications
Jul 15, 2024
2024

DocTIS article in magazine "EU Research"

Article in EU Research
In the News
Mar 11, 2024
2024

Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

Seven-chain adaptive immune receptor repertoire
In the News
Mar 4, 2024
2024

UCB announces strategic investment in IMIDomics, Inc to advance breakthrough solutions for immune-mediated inflammatory diseases

https://www.ucb.com/stories-media
Press Releases
Dec 6, 2023
2023

IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development

https://www.businesswire.com/news/
In the News
Nov 15, 2023
2023

IMIDomics Strengthens its Leadership with the Addition of Dr. Eric Perakslis to its Executive Team and Dr. Ramon Felciano to its Advisory Team

https://www.businesswire.com/news/
Press Releases
Oct 11, 2023
2023

IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs

https://www.businesswire.com/news
Press Releases
Oct 4, 2023
2023

IMIDomics Announces Strategic Agreement with WuXi Biologics to Advance IMB1001 Antibody Development for Immune-Mediated Inflammatory Diseases

https://www.businesswire.com/news
Publications
Sep 28, 2023
2023

Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes

https://academic.oup.com/
In the News
Sep 27, 2023
2023

Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases

https://www.businesswire.com/news
In the News
Sep 27, 2023
2023

Founder of IMIDomics receives the Trifermed Award for Social Impact in Healthcare

https://awards.trifermed.com/
Sep 6, 2023
2023

IMIDomics Inc. Secures Exclusive Worldwide Licensing Agreement with TNAX Biopharma Corporation for TNAX101A (IMB1001), A Promising Drug Candidate for Immune-Mediated Inflammatory Diseases

www.businesswire.com/news
Publications
Aug 29, 2023
2023

Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches

https://pubmed.ncbi.nlm.nih.gov
Publications
Apr 1, 2023
2023

Influenza Adverse Events in Patients with rheumatoid arthritis, ulcerative colitis, or psoriatic arthritis in the Tofacitinib Clinical Development Programs

pubmed.ncbi.nlm.nih.gov
In the News
Dec 7, 2022
2022

IMIDomics Announces Appointment of Key Science and Medical Research Experts to Newly Formed Immunology Advisory Board

Businesswire.com
Publications
Dec 1, 2022
2022

Association of class II HLA alleles with susceptibility to develop immune-mediated diseases in Paraguayan patients

onlinelibrary.wiley.com
Publications
Nov 1, 2022
2022

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

pubmed.ncbi.nlm.nih.gov
Publications
Aug 1, 2022
2022

Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study

pubmed.ncbi.nlm.nih.gov
In the News
Mar 23, 2022
2022

CataloniaBio & HealthTech has awarded IMIDomics with the Bioèxit Award | Award acceptance speech by co-founder and CMO, Dr. Sara Marsal

Cataloniabioht.org
In the News
Feb 15, 2022
2022

IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE

Businesswire.com
Publications
Jan 1, 2022
2022

Food groups associated with IMIDS: Mendelian randomization and disease severity study

doi.org
Publications
Jan 1, 2022
2022

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

pubmed.ncbi.nlm.nih.gov
In the News
Dec 7, 2021
2021

IMIDomics™ Announces Scientific and Business Advisory Boards

Businesswire.com
Publications
Dec 1, 2021
2021

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

pubmed.ncbi.nlm.nih.gov
Publications
Dec 1, 2021
2021

Mapping the human genetic architecture of COVID-19

pubmed.ncbi.nlm.nih.gov
In the News
Oct 7, 2021
2021

IMIDomics sponsors the online Symposium “Combination therapies in common diseases: clinical and translational challenges”, October 7th 2021

Doctis.eu
In the News
Jul 27, 2021
2021

IMIDomics™ Closes $16.5 Million Series A Financing to Advance its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases

Businesswire.com
In the News
Jul 20, 2021
2021

IMIDomics co-organizes symposium "Combination therapies in common diseases: clinical and translational challenges"

Doctis.eu
Publications
Jun 1, 2021
2021

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

pubmed.ncbi.nlm.nih.gov
Publications
May 1, 2021
2021

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

thelancet.com
Publications
Apr 1, 2021
2021

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

doi.org
Publications
Apr 1, 2021
2021

Food groups associated with IMIDS: Mendelian randomization and disease severity study

doi.org
Publications
Apr 1, 2021
2021

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

doi.org
In the News
Oct 16, 2020
2020

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

Nih.gov
Publications
Jun 1, 2020
2020

Complement genes contribute sex-biased vulnerability in diverse disorders

pubmed.ncbi.nlm.nih.gov
Publications
Jun 1, 2020
2020

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

pubmed.ncbi.nlm.nih.gov
In the News
May 20, 2020
2020

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

Arxiv.org
Publications
May 1, 2020
2020

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

pubmed.ncbi.nlm.nih.gov
In the News
Feb 2, 2020
2020

IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases

Businesswire.com
Publications
Feb 1, 2020
2020

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

doi.org
Publications
Jan 1, 2020
2020

A questionnaire-based study on contraceptive practice in patients with rheumatic disease found no significant difference in age-matched healthy controls

doi.org
Publications
Jan 1, 2020
2020

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis

doi.org
In the News
Dec 1, 2019
2019

IMIDomics granted Horizon 2020 project on Systems approaches for the discovery of combinatorial therapies for complex disorders

Doctis.eu
Publications
Mar 1, 2019
2019

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

https://pubmed.ncbi.nlm.nih.gov
Publications
Jan 1, 2019
2019

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease

doi.org
Publications
Jan 1, 2019
2019

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in rheumatoid arthritis

europepmc.org
Publications
Jan 1, 2019
2019

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

europepmc.org
Publications
Jan 1, 2018
2018

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

doi.org
Publications
Jan 1, 2018
2018

Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

doi.org
Publications
Jan 1, 2017
2017

aRNApipe: a balanced, efficient and distributed pipeline for processing RNA-seq data in high-performance computing environments

Publications
Jan 1, 2017
2017

Leveraging Molecular Data Analysis to Understand Drug Response in Systemic Sclerosis.

Publications
Jan 1, 2017
2017

Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.

Publications
Jan 1, 2017
2017

Genetic variation associated with cardiovascular risk in autoimmune diseases.

Publications
Jan 1, 2017
2017

Epigenome-wide association study of rheumatoid arthritis identifies differentially methylated loci in B cells.

Publications
Jan 1, 2017
2017

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts

In the News
Mar 11, 2024

Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

Seven-chain adaptive immune receptor repertoire
In the News
Mar 4, 2024

UCB announces strategic investment in IMIDomics, Inc to advance breakthrough solutions for immune-mediated inflammatory diseases

https://www.ucb.com/stories-media
In the News
Nov 15, 2023

IMIDomics Strengthens its Leadership with the Addition of Dr. Eric Perakslis to its Executive Team and Dr. Ramon Felciano to its Advisory Team

https://www.businesswire.com/news/
In the News
Sep 27, 2023

Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases

https://www.businesswire.com/news
In the News
Sep 27, 2023

Founder of IMIDomics receives the Trifermed Award for Social Impact in Healthcare

https://awards.trifermed.com/
In the News
Dec 7, 2022

IMIDomics Announces Appointment of Key Science and Medical Research Experts to Newly Formed Immunology Advisory Board

Businesswire.com
In the News
Mar 23, 2022

CataloniaBio & HealthTech has awarded IMIDomics with the Bioèxit Award | Award acceptance speech by co-founder and CMO, Dr. Sara Marsal

Cataloniabioht.org
In the News
Feb 15, 2022

IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE

Businesswire.com
In the News
Dec 7, 2021

IMIDomics™ Announces Scientific and Business Advisory Boards

Businesswire.com
In the News
Oct 7, 2021

IMIDomics sponsors the online Symposium “Combination therapies in common diseases: clinical and translational challenges”, October 7th 2021

Doctis.eu
In the News
Jul 27, 2021

IMIDomics™ Closes $16.5 Million Series A Financing to Advance its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases

Businesswire.com
In the News
Jul 20, 2021

IMIDomics co-organizes symposium "Combination therapies in common diseases: clinical and translational challenges"

Doctis.eu
In the News
Oct 16, 2020

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

Nih.gov
In the News
May 20, 2020

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

Arxiv.org
In the News
Feb 2, 2020

IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases

Businesswire.com
In the News
Dec 1, 2019

IMIDomics granted Horizon 2020 project on Systems approaches for the discovery of combinatorial therapies for complex disorders

Doctis.eu
Publications
2024

DocTIS article in magazine "EU Research"

Article in EU Research
Publications
2023

Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes

https://academic.oup.com/
Publications
2023

Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches

https://pubmed.ncbi.nlm.nih.gov
Publications
2023

Influenza Adverse Events in Patients with rheumatoid arthritis, ulcerative colitis, or psoriatic arthritis in the Tofacitinib Clinical Development Programs

pubmed.ncbi.nlm.nih.gov
Publications
2022

Association of class II HLA alleles with susceptibility to develop immune-mediated diseases in Paraguayan patients

onlinelibrary.wiley.com
Publications
2022

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

pubmed.ncbi.nlm.nih.gov
Publications
2022

Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study

pubmed.ncbi.nlm.nih.gov
Publications
2022

Food groups associated with IMIDS: Mendelian randomization and disease severity study

doi.org
Publications
2022

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

pubmed.ncbi.nlm.nih.gov
Publications
2021

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

pubmed.ncbi.nlm.nih.gov
Publications
2021

Mapping the human genetic architecture of COVID-19

pubmed.ncbi.nlm.nih.gov
Publications
2021

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

pubmed.ncbi.nlm.nih.gov
Publications
2021

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

thelancet.com
Publications
2021

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

doi.org
Publications
2021

Food groups associated with IMIDS: Mendelian randomization and disease severity study

doi.org
Publications
2021

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

doi.org
Publications
2020

Complement genes contribute sex-biased vulnerability in diverse disorders

pubmed.ncbi.nlm.nih.gov
Publications
2020

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

pubmed.ncbi.nlm.nih.gov
Publications
2020

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

pubmed.ncbi.nlm.nih.gov
Publications
2020

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

doi.org
Publications
2020

A questionnaire-based study on contraceptive practice in patients with rheumatic disease found no significant difference in age-matched healthy controls

doi.org
Publications
2020

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis

doi.org
Publications
2019

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

https://pubmed.ncbi.nlm.nih.gov
Publications
2019

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease

doi.org
Publications
2019

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in rheumatoid arthritis

europepmc.org
Publications
2019

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

europepmc.org
Publications
2018

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

doi.org
Publications
2018

Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

doi.org
Publications
2017

aRNApipe: a balanced, efficient and distributed pipeline for processing RNA-seq data in high-performance computing environments

Publications
2017

Leveraging Molecular Data Analysis to Understand Drug Response in Systemic Sclerosis.

Publications
2017

Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.

Publications
2017

Genetic variation associated with cardiovascular risk in autoimmune diseases.

Publications
2017

Epigenome-wide association study of rheumatoid arthritis identifies differentially methylated loci in B cells.

Publications
2017

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts

Press Releases
Dec 6, 2023

IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development

https://www.businesswire.com/news/
Press Releases
Oct 11, 2023

IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs

https://www.businesswire.com/news
Press Releases
Oct 4, 2023

IMIDomics Announces Strategic Agreement with WuXi Biologics to Advance IMB1001 Antibody Development for Immune-Mediated Inflammatory Diseases

https://www.businesswire.com/news
Discovering and developing the next generation of medicines for immune-mediated inflammatory diseases